Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Pfizer expands Healthcare Hub programme for tech startups

London, Stockholm, Sydney and Toronto hubs open their doors

Pfizer

Pfizer has expanded its Healthcare Hub programme to provide support and resources to late-stage health tech startups.

The pharma company’s initiative was first brought to centres in New York, Berlin and Tel Aviv, and last month London, Stockholm, Sydney and Toronto hubs opened their doors.

The programme seeks startups who have developed a product or service ready for use by healthcare professionals that can show evidence of benefits to patients or clinicians.

For the London hub at stake is a share of a £56,000 grant and a year-long support programme to help with, among other things, navigating the UK’s health system. They can, however, retain complete independence from the pharma firm with no obligation to transfer intellectual property or equity to Pfizer.

Erik Nordkamp, Pfizer UK’s managing director, said: “I’m delighted that we’ll be launching the Pfizer Healthcare Hub here in the UK.

“We live in a country that is already a centre for original thinking and innovation within healthcare and our goal is to accelerate the success of the brightest start-ups in this field and help them make a difference to patients.”

Pfizer UK will this week shortlist up to 10 UK-registered companies and charities, inviting them to its Walton Oaks headquarters in Surrey.

There they will pitch their offering on 18 May to a panel of business and health leaders, among them Dr Sam Barrell from the Taunton and Somerset NHS Foundation Trust and Anna King, commercial director at the Health Innovation Network and Digital Health London. Three winners will then be announced in June.

Dr Hamish Graham, manager of Pfizer Healthcare Hub: London, said: “The Healthcare Hub will provide a platform for start-ups to harness Pfizer’s global network, enabling them to get access to our expertise, understanding and guidance.

“We hope, with our support, that they’ll be able to reach their goals and get their innovations adopted within the health service.”

Pfizer’s startup programme echoes similar work in the space by the likes of LEO Pharma and its innovation lab, Merck’s digital health accelerator, Bayer, MSD in the UK and Sandoz in mobile health.

5th May 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M3 (EU)

M3 was founded in 2000 with the goal of changing the world of medicine through making full use of the...

Latest intelligence

Cutting through the noise
AstraZeneca looks to lead an R&D revolution as the company invests in CRISPR and functional genomics drug discovery...
International Childhood Cancer Day 2019
The number of new cases per year is shocking but the journey and the outlooks have vastly improved. We've pulled together an infographic to show just what we mean with...
Immuno-oncology in 2019: the rapid evolution continues
Immunotherapy is pharma’s biggest growth driver – how will it develop in 2019?...

Infographics